119 related articles for article (PubMed ID: 37199420)
1. Determination of Orelabrutinib in Human Plasma Using LC-MS/MS.
Zhao Y; Guo YJ; Chen XL; Yang YL; Ma H; Wang YQ; Sun LN
Ther Drug Monit; 2023 Oct; 45(5):599-605. PubMed ID: 37199420
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.
Sun LN; Zhao Y; Qian ZY; Chen XL; Ma H; Guo YJ; Shen H; Wang YQ
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770870
[TBL] [Abstract][Full Text] [Related]
3. Quantification of orelabrutinib in human plasma and cerebrospinal fluid by liquid chromatography tandem mass spectrometry.
Ji S; Liu X; Ha J; Ai L; Li Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Apr; 1221():123680. PubMed ID: 36989941
[TBL] [Abstract][Full Text] [Related]
4. Quantification of cefaclor in human plasma using SIL-IS LC-ESI-MS/MS for pharmacokinetics study in healthy Chinese volunteers.
Chen X; Liu G; Wang C; Liu R; Wang M; Huang Y; Shen J; Jia Y
Biomed Chromatogr; 2023 Aug; 37(8):e5638. PubMed ID: 37002731
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Determination of Ibrutinib, Dihydroxydiol Ibrutinib, and Zanubrutinib in Human Plasma by Liquid Chromatography-Mass Spectrometry/Mass Spectrometry.
Guo YJ; Du TT; Yang YL; Zhao Y; Chen XL; Ma H; Sun LN; Wang YQ
Ther Drug Monit; 2024 Mar; ():. PubMed ID: 38531816
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS methods for determination of venetoclax in human plasma and cerebrospinal fluid.
Yang YL; Qian ZY; Zhao Y; Chen XL; Huang QY; Guo YJ; Sun LN; Wang YQ
Biomed Chromatogr; 2023 Dec; 37(12):e5738. PubMed ID: 37724003
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS.
Huynh HH; Pressiat C; Sauvageon H; Madelaine I; Maslanka P; Lebbé C; Thieblemont C; Goldwirt L; Mourah S
Ther Drug Monit; 2017 Feb; 39(1):43-54. PubMed ID: 27861317
[TBL] [Abstract][Full Text] [Related]
8. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
[TBL] [Abstract][Full Text] [Related]
9. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
Al Shirity ZN; Westra N; Hateren KV; Munnink THO; Kosterink JGW; Mian P; Hooge MNL; Touw DJ; Gareb B
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123872. PubMed ID: 37716342
[TBL] [Abstract][Full Text] [Related]
10. Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics.
Liu YN; Hu Y; Wang J; Chen C; Cai J; Xu RA; Lu Z
Front Pharmacol; 2022; 13():991281. PubMed ID: 36147349
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
12. A semi-automated LC-MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma.
Li W; Luo S; Rebello S; Flarakos J; Tse FL
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():182-93. PubMed ID: 24814004
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer.
Feng X; Ding Y; Zhang P; Fu Q; Zhang L; Zheng H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122940. PubMed ID: 34564058
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel LC-MS/MS method for simultaneous quantitative determination of tyrosine kinase inhibitors in human plasma.
Lou Y; Qin H; Hu Q; Chai Y; Zhou H; Chen M; Wang Q; Huang P; Gu J; Zhang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123394. PubMed ID: 35932695
[TBL] [Abstract][Full Text] [Related]
15. Determination of Sodium Tanshinone IIA Sulfonate in human plasma by LC-MS/MS and its application to a clinical pharmacokinetic study.
Qin W; Wang B; Lu X; Liu H; Wang L; Qi W
J Pharm Biomed Anal; 2016 Mar; 121():204-208. PubMed ID: 26812478
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid.
Beauvais D; Goossens JF; Boyle E; Allal B; Lafont T; Chatelut E; Herbaux C; Morschhauser F; Genay S; Odou P; Danel C
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():158-166. PubMed ID: 30029202
[TBL] [Abstract][Full Text] [Related]
17. A simple and sensitive LC-MS/MS method for determination of doxylamine in human plasma and its application in a bioequivalence study in healthy Chinese volunteers.
Fu R; Sheng M; Yang C; Liu L; Xiong W; Wang X; Chen X; Yu Z; Gao Y; Tan H; Xin C; Zhang H
J Pharm Biomed Anal; 2022 Oct; 220():114984. PubMed ID: 35994945
[TBL] [Abstract][Full Text] [Related]
18. A liquid chromatography-tandem mass spectrometry method for simultaneous quantification of thirty-nine tyrosine kinase inhibitors in human plasma.
Guo ZX; Wu YE; Shi HY; van den Anker J; Liang P; Zheng Y; Zhao XW; Feng R; Zhao W
J Pharm Biomed Anal; 2023 Feb; 224():115159. PubMed ID: 36442459
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of a LC-MS/MS method for the determination of anlotinib in human plasma: Application to therapeutic drug monitoring.
Yu M; Liang Z; Xiong L; Liu F; Cheng L; Jia C; Qi X; Sun F
Biomed Chromatogr; 2022 Dec; 36(12):e5501. PubMed ID: 36082703
[TBL] [Abstract][Full Text] [Related]
20. An LC-MS/MS method for rapid and sensitive high-throughput simultaneous determination of various protein kinase inhibitors in human plasma.
Abdelhameed AS; Attwa MW; Kadi AA
Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27450926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
